✦ LIBER ✦

Cost implications of end-stage liver disease without transplantation

Book ID: 121645038
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1997
Weight: 111 KB
Volume: 123
Category: Article
ISSN: 1173-5503
DOI: 10.1007/BF03271860

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End-stage renal disease in liver transpl

End-stage renal disease in liver transplants

✍ Melissa Lynn; Kenneth Abreo; Gazi Zibari; John McDonald 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Su1293 Celiac Disease and End-Stage Live

Su1293 Celiac Disease and End-Stage Liver Disease Requiring Liver Transplantation

✍ Tsai, Chung-Jyi; Tsai, Grace 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

End-Stage Liver Disease: Challenges and

End-Stage Liver Disease: Challenges and Practice Implications

✍ Hansen, Lissi; Sasaki, Anna; Zucker, Betsy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Liver transplantation cost in the model

Liver transplantation cost in the model for end-stage liver disease era: Looking beyond the transplant admission

✍ Paula Buchanan; Nino Dzebisashvili; Krista L. Lentine; David A. Axelrod; Mark A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

We examined the relationship between the total cost incurred by liver transplantation (LT) recipients and their Model for End-Stage Liver Disease (MELD) score at the time of transplant. We used a novel database linking billing claims from a large private payer with the Organ Procurement and Transpla

Living related liver transplantation for

✍ G. Testa; M. Malaga; S. Nadalin; C. Valentin-Gamazo; A. Frilling; C.E. Broelsch 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation

✍ Takafumi Ichida; Yutaka Narita; Romi Murakami 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 102 KB